Antimicrobial resistance disproportionately affects low- and middle-income countries. Data is needed to track and tackle this threat. But collecting data in these countries can be challenging. Dr Andrew Kambugu, medical doctor and Sande McKinnell Executive Director at the Infectious Diseases Institute (IDI) at Makerere University, sets out some of the challenges in our latest ‘Behind the Research’ newsletter - and how CAMO-Net is working to tackle them. “The picture of antimicrobial resistance is evolving - it’s like a moving target. If you can’t observe that target moving, you can’t hit it. That’s why data is so important.” Learn more from Andrew ⤵
We are glad to be leading the way to gathering quality data to respond to AMR and Infectious Disease. We welcome like minded individuals to join the Alliance
Anja Leetz
2mo
Data is important for policy decision making. What you can't measure, you can't change. At the same time we need good science communication that can translate and explain data to non-experts, enabling good decision making.
Drajay Jain
2mo
Right diagnosis followed by needed right most effective drug for required period is the best way for treating any infection. AMR is happening due to some missing approach. To fill this gap there is a great need of good clear understanding & TRUST between treating doctor and patient.
I agree!
I agree
Doctoral Student at Auckland University of Technology specializing in Public Health
2moData is indeed crucial for tackling antimicrobial resistance, especially in LMICs. However, it's disheartening that many scientific journals often reject surveillance studies from these regions, deeming them not impactful enough. This not only undermines the importance of local data but also hinders the global effort to address AMR effectively.